Jeffrey E Robbins

US Patent:

6692253, Feb 17, 2004

Filed:

Oct 12, 2001

Appl. No.:

09/976385

Inventors:

Charles Brockway - Greenville OH
Jeffrey Lyn Robbins - Greenville OH

Assignee:

Midmark Corporation - Versailles OH

International Classification:

A61C 1500

US Classification:

433 77, 312209

Abstract:

An instrument delivery head for supporting hand-held instruments used in dental and other medical procedures. The instrument delivery head includes base and a lid connected to the base for movement between open and closed positions. Various instrument controls are supported by the lid so that the controls are accessible when the lid is opened. After the control adjustments are made, the lid is closed to conceal the controls within the instrument delivery head.

US Patent:

7078510, Jul 18, 2006

Filed:

Jul 3, 2003

Appl. No.:

10/613728

Inventors:

Jeffrey Robbins - Cincinnati OH, US

Assignee:

Children's Hospital Medical Center - Cincinnati OH

International Classification:

C07H 21/04
C12N 5/00
C12N 15/74

US Classification:

536 231, 4353201, 435325

Abstract:

The methods and compositions of the present invention find use in altering cardiac-preferred expression in transgenic animals. The compositions of the invention include isolated nucleic acid molecules, expression cassettes, animal cells, transgenic animals, and transgenic mice. The transgenic animals of the invention exhibit inducible cardiac preferred expression of a nucleotide sequence of interest. The methods allow generation of transgenic animals with altered cardiac preferred expression of the nucleotide sequence of interest. In particular, the invention provides a method for altering the susceptibility of a transgenic animal to cardiopathy. A transgenic animal of the invention finds use in identifying anti-cardiopathic compounds.

US Patent:

20040229360, Nov 18, 2004

Filed:

Mar 11, 2004

Appl. No.:

10/798037

Inventors:

Jeffrey Robbins - Cincinnati OH, US

International Classification:

C12N005/06
C12N015/85

US Classification:

435/455000, 435/325000

Abstract:

The methods and compositions of the present invention find use in altering cardiac-preferred expression in transgenic animals. The compositions of the invention include animal cells, transgenic animals, and transgenic rabbits. The transgenic animals of the invention exhibit altered cardiac preferred expression of a heterologous nucleotide sequence. The methods allow generation of transgenic animals with altered cardiac preferred expression of the heterologous nucleotide sequence. In particular, the invention provides a method for altering the susceptibility of a transgenic animal to cardiopathy. A transgenic animal of the invention finds use in identifying anti-cardiopathic compounds.